TR201820964T4 - Antibiyotiğe karşı dirençli bakteri enfeksiyonunun tedavisi. - Google Patents

Antibiyotiğe karşı dirençli bakteri enfeksiyonunun tedavisi. Download PDF

Info

Publication number
TR201820964T4
TR201820964T4 TR2018/20964T TR201820964T TR201820964T4 TR 201820964 T4 TR201820964 T4 TR 201820964T4 TR 2018/20964 T TR2018/20964 T TR 2018/20964T TR 201820964 T TR201820964 T TR 201820964T TR 201820964 T4 TR201820964 T4 TR 201820964T4
Authority
TR
Turkey
Prior art keywords
susceptible
bacteria
treatment
bacterial infection
antibiotic resistant
Prior art date
Application number
TR2018/20964T
Other languages
English (en)
Turkish (tr)
Inventor
Hsu Ming-Chu
Richard King Chi-Hsin
Chen Shu-Jen
Lin Luke
Original Assignee
Taigen Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taigen Biotechnology Co Ltd filed Critical Taigen Biotechnology Co Ltd
Publication of TR201820964T4 publication Critical patent/TR201820964T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TR2018/20964T 2008-07-01 2008-09-08 Antibiyotiğe karşı dirençli bakteri enfeksiyonunun tedavisi. TR201820964T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7729308P 2008-07-01 2008-07-01

Publications (1)

Publication Number Publication Date
TR201820964T4 true TR201820964T4 (tr) 2019-01-21

Family

ID=41464848

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2018/20964T TR201820964T4 (tr) 2008-07-01 2008-09-08 Antibiyotiğe karşı dirençli bakteri enfeksiyonunun tedavisi.

Country Status (13)

Country Link
US (1) US8211909B2 (enExample)
EP (1) EP2303271B1 (enExample)
JP (1) JP2011526887A (enExample)
KR (2) KR20150006080A (enExample)
CN (1) CN101618038B (enExample)
AU (1) AU2008358909B2 (enExample)
CA (1) CA2728328C (enExample)
EA (1) EA018653B1 (enExample)
NZ (1) NZ588898A (enExample)
TR (1) TR201820964T4 (enExample)
TW (1) TWI375558B (enExample)
WO (1) WO2010002415A1 (enExample)
ZA (1) ZA201100616B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101392808B1 (ko) * 2011-12-30 2014-05-12 순천대학교 산학협력단 식물 추출물 또는 이의 분획물을 포함하는 항균용 조성물
CN103145615B (zh) * 2013-03-20 2015-07-29 浙江医药股份有限公司 一种奈诺沙星螯合物的后处理方法
KR101392810B1 (ko) * 2013-09-25 2014-05-12 순천대학교 산학협력단 된장풀 추출물 또는 이의 분획물을 포함하는 항균용 조성물
US9492374B2 (en) 2015-03-25 2016-11-15 Jose Rafael Salinas Andrade Composition and method for treatment of ulcers
CN105368825B (zh) * 2015-10-14 2019-09-10 华东医院 幽门螺杆菌抗生素耐药性分析试剂盒及耐药性检测方法
US12358902B2 (en) * 2017-12-11 2025-07-15 Denovamed Inc. 5-(2,5-bis(4-chloro-2-isopropylphenyl)thiophen-3-yl)-1H-tetrazole for the topical treatment of bacterial infections
CN111979292B (zh) * 2020-07-27 2022-08-05 广东省微生物研究所（广东省微生物分析检测中心） 一种同时携带多重耐药基因cfr和lsa(E)的MRSA的用途
CN114437026A (zh) * 2021-10-26 2022-05-06 浙江医药股份有限公司新昌制药厂 一种低组合物杂质的苹果酸奈诺沙星原料药及其制备方法
CN118852222B (zh) * 2024-06-27 2025-09-05 南京桦冠生物技术有限公司 一种奈诺沙星中间体及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US100800A (en) 1870-03-15 Improvement in riding attachments for plows
US3989816A (en) 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4444762A (en) 1980-04-04 1984-04-24 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclopentan-2-ones
EP1015445B1 (en) 1997-09-15 2009-02-25 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
US6387928B1 (en) * 1997-09-15 2002-05-14 The Procter & Gamble Co. Antimicrobial quinolones, their compositions and uses
US6348624B1 (en) 1998-01-09 2002-02-19 The Procter & Gamble Co. Process for making certain benzoic acid compounds
DK1343766T3 (da) 2000-12-14 2005-10-31 Procter & Gamble Procestrin med cyklisering ved fremstilling af quinoloner og naphthyridiner
US6900224B2 (en) * 2002-07-31 2005-05-31 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
US6803469B2 (en) 2002-08-05 2004-10-12 The Procter & Gamble Company Process for preparing quinolone antibiotic intermediates
WO2005026145A2 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Quinolone antibacterial agents
DK2001862T3 (da) 2006-03-28 2011-08-08 Warner Chilcott Co Llc Malatsalte og polymorfe af (3S,5S)-7-[3-amino-5-methyl-piperidinyl]-1-cyklopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolincarboxylsyre
JP4876165B2 (ja) 2006-03-28 2012-02-15 ザ プロクター アンド ギャンブル カンパニー キノロン中間体を調製するための水素化物還元法
BRPI0709220A2 (pt) * 2006-03-28 2011-07-12 Procter & Gamble processo de acoplamento para preparo de intermediários de quinolona
US8658183B2 (en) 2007-08-09 2014-02-25 Taigen Biotechnology Company, Ltd. Antimicrobial parenteral formulation
US20120157492A1 (en) 2008-07-15 2012-06-21 Taigen Biotechnology Co., Ltd. Antibiotic drug

Also Published As

Publication number Publication date
EA201170121A1 (ru) 2011-06-30
EP2303271B1 (en) 2018-11-07
ZA201100616B (en) 2011-10-26
US8211909B2 (en) 2012-07-03
JP2011526887A (ja) 2011-10-20
HK1139049A1 (en) 2010-09-10
TWI375558B (en) 2012-11-01
EP2303271A1 (en) 2011-04-06
CN101618038A (zh) 2010-01-06
EA018653B1 (ru) 2013-09-30
NZ588898A (en) 2012-09-28
EP2303271A4 (en) 2012-01-25
TW201002322A (en) 2010-01-16
CA2728328C (en) 2015-02-24
WO2010002415A1 (en) 2010-01-07
CN101618038B (zh) 2011-12-07
US20100004282A1 (en) 2010-01-07
AU2008358909B2 (en) 2012-12-13
KR20110044168A (ko) 2011-04-28
CA2728328A1 (en) 2010-01-07
KR20150006080A (ko) 2015-01-15
AU2008358909A1 (en) 2010-01-07

Similar Documents

Publication Publication Date Title
TR201820964T4 (tr) Antibiyotiğe karşı dirençli bakteri enfeksiyonunun tedavisi.
NZ593111A (en) Antibacterial compounds
EP2569434A4 (en) COMPOSITIONS AND METHODS OF TREATING LEUKEMIA
WO2013122888A3 (en) Methods of treating bacterial infections
MX348974B (es) Derivados 1,6 - diazabiciclo [3,2,1] octan-7-ona y su uso en el tratamiento de infecciones bacterianas.
EA201071032A1 (ru) Гетероциклическое соединение
TN2014000297A1 (en) Amidine substituted beta - lactam compounds, their preparation and use as antibacterial agents
PH12012501841B1 (en) Anti-infective compounds
EA201190095A1 (ru) Производные актагардина
MX352760B (es) Metodos para tratar infecciones intrapulmonares.
WO2011071904A3 (en) Inhibiting bacterial infection and biofilm formation
MX2019006620A (es) Composiciones de polisacaridos y metodos de uso.
MX2015012472A (es) Derivados de manosa para el tratamiento de infecciones bacterianas.
MX2011005425A (es) Derivados de carboxiamida lantibiotica con actividad antibacteriana mejorada.
MX2014001599A (es) 3,4-dihidro-1h-[1,8]naftiridinosas sustituidas con piperidinilo antibacterianas.
PH12015502375B1 (en) Antimicrobial compounds and methods of making and using the same
UA107346C2 (en) Use of nifuratel to treat infections caused by atopobium species
HK1222339A1 (zh) 金属-β-内酰胺酶的抑制剂
MY165011A (en) Antimicrobial compounds and methods of making and using the same
MX2015005753A (es) Agentes antimicrobianos.
MX2009009074A (es) Macrolidos basados en eritromicina.
BR112012029262A2 (pt) métodos de tratamento de infecção bacteriana recorrente
MX337145B (es) Composiciones farmaceuticas.
EA201070295A1 (ru) Лечение рака легких
IN2014CN03886A (enExample)